SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

Search

Eurofins Scientific SE

Slēgts

62.58 0.94

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

62.56

Max

62.96

Galvenie mērījumi

By Trading Economics

Ienākumi

105M

228M

Pārdošana

1.9B

3.7B

P/E

Sektora vidējais

27.271

77.607

EPS

1.221

Dividenžu ienesīgums

1.03

Peļņas marža

6.2

Darbinieki

65,694

EBITDA

285M

693M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+25.16% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.03%

3.49%

Nākamie ieņēmumi

2026. g. 22. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-320M

12B

Iepriekšējā atvēršanas cena

61.64

Iepriekšējā slēgšanas cena

62.58

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bearish Evidence

Eurofins Scientific SE Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 24. apr. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Group Rejects EQT's Revised Offer

2026. g. 24. apr. 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Scoring the Cook Era -- Barrons.com

2026. g. 24. apr. 20:51 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:50 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 24. apr. 20:39 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:09 UTC

Peļņas

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

2026. g. 24. apr. 19:48 UTC

Tirgus saruna
Galvenie ziņu notikumi

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

2026. g. 24. apr. 19:22 UTC

Peļņas

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

2026. g. 24. apr. 19:06 UTC

Peļņas

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

2026. g. 24. apr. 19:05 UTC

Tirgus saruna

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

2026. g. 24. apr. 18:30 UTC

Iegādes, apvienošanās, pārņemšana

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

2026. g. 24. apr. 18:28 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Rejects Revised EQT Offer

2026. g. 24. apr. 18:12 UTC

Tirgus saruna

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

2026. g. 24. apr. 18:06 UTC

Tirgus saruna

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

2026. g. 24. apr. 17:42 UTC

Peļņas

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Peļņas

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Tirgus saruna

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

2026. g. 24. apr. 17:12 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 24. apr. 17:11 UTC

Tirgus saruna

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

2026. g. 24. apr. 17:09 UTC

Tirgus saruna
Peļņas

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

2026. g. 24. apr. 17:09 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 17:06 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

2026. g. 24. apr. 16:51 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 24. apr. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Eurofins Scientific SE Prognoze

Cenas mērķis

By TipRanks

25.16% augšup

Prognoze 12 mēnešiem

Vidējais 77.35 EUR  25.16%

Augstākais 81 EUR

Zemākais 73.7 EUR

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Eurofins Scientific SE — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

1

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

54.22 / 56.82Atbalsts un pretestība

Īstermiņā

Weak Bearish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Bullish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat